Purpose Lymphoma is a health outcome of interest for drug safety studies. Studies using administrative claims data require the accurate identification of lymphoma cases. We developed and validated an International Classification of Diseases, Tenth Revision, Clinical Modification (ICD‐10‐CM)‐based ...
lymphomas malignant,Lymphomatous,Malignant lymphoma NOS (disorder),[M]Reticulolymphosarcoma NOS,[M]Malignant lymphoma NOS (disorder),Malignant lymphoma NOS of unspecified site (disorder),Lymphoma morphology (morphologic abnormality),Lymphosarcoma,Malignant lymphoma, no ICD-O subtype (morphologic abnormality)...
White arrowheads indicate nuclear Notch2 ICD. Scale bar, 10 μm. (G) ChIP analysis of RBPJ activity in LCs after Notch inhibition. shN1 and shN2 denote shRNA against Notch1 and Notch2, respectively; n = 4. (H–K) Aggressive features of LCs were tested after disruption of Notch2-Hey...
Patients with a first PMBCL ICD-10-CM diagnosis (with or without an antecedent ICD-10-CM diagnosis of DLBCL/other lymphoma, which may have been assigned before PMBCL confirmation) after 10/01/2015 (index date) and no ICD-9-CM diagnosis code for unspecified PMBCL/DLBCL were identified as ...
irAEs were identified through a set of validated ICD-10-CM codes.Results:Within the study period, a total of 567 patients with HL were identified. Among them, 363 (63.8%) patients received nivolumab and 263 (46.4%) received pembrolizumab. The mean age was 50.1 (SD 19.6) years-old, 227...
Methods: Adults with a histologic diagnosis of non-Hodgkin lymphoma (ICD-O-3 9590-9823) and a primary site coded as vulva (ICD-10-CM C51.0-51.9), vagina (C52.9), cervix (C53.0-53.9), uterus (C54.0-C55.9), or ovary (C56.9-C57.4) diagnosed between 1973 and 2015 were included in ...
Pts with ≥12 months of clinical activity prior to the index date, ≥1 hospitalization or ≥2 OP encounters with an ICD‐9/10‐CM diagnosis of cHL prior to the index date, no diagnosis of nodular lymphocyte‐predominant HL, and ≥18 years of age were included. Baseline characteristics were...
Since spontaneous canine and human lymphomas share a similar biological behavior [12,13], dogs represent an excellent opportunity for the performance of translational research studies [10,14–16]. Here, we explore the in vitro sensitivity of both canine and human lymphoma cells to a lentogenic (...
(Tt-h2a5t hcealrlbso, rw MeMdTerViv) ed a siBamancanughAdneibasaidhcLcysilee lntBngB errisenr/gmAatongetcLwmteaen mB- venuwac/ai icdnhcicir ntihaiheBzha loeesn AilpsrdmeutetLa n ssnntmrp.Bgh eateF/eenmunvu ctrnwsaaereihtidlroczh iioTi tna...